GL
KITE

GLG LLC’s Kite Pharma, Inc. KITE Stock Holding History

GLG LLC’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30,702
Closed -$1.38M – 588
2016
Q4 		$1.38M Buy
30,702
+1,952
+7% +$95.8K 0.1% 226
2016
Q3 		$1.61M Buy
28,750
+3,750
+15% +$209K 0.11% 203
2016
Q2 		$1.25M Buy
+25,000
New +$1.23M 0.09% 223
2015
Q4 		– Sell
-109,031
Closed -$6.07M – 628
2015
Q3 		$6.07M Sell
109,031
-25,459
-19% -$1.6M 0.15% 160
2015
Q2 		$8.2M Buy
134,490
+79,685
+145% +$4.55M 0.17% 149
2015
Q1 		$3.16M Buy
54,805
+47,305
+631% +$3.17M 0.09% 248
2014
Q4 		$433K Buy
+7,500
New +$316K 0.01% 558

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return